EMEA-003520-PIP01-23 - paediatric investigation plan
motugivatrep
PIPHuman
Key facts
- Active Substance
- motugivatrep
- Therapeutic area
- Eye disorders
- Decision number
- P/0066/2024
- PIP number
- EMEA-003520-PIP01-23
- Pharmaceutical form(s)
- Eye drops, suspension
- Condition(s) / indication(s)
- Treatment of dry eye disease
- Route(s) of administration
- Ophthalmic use
- Contact for public enquiries
Senju Pharmaceutical Co. Ltd
E-mail: andre.sousa@ppd.com
Tel: +351 308804284- Decision type
- W: decision granting a waiver in all age groups for all conditions or indications
- Decision date